Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty-Reference-Cited by-同舟云学术

Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty

Published:2017-08-28 Issue:10 Volume:17 Page:951-964
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Segelov Eva¹,Lordick Florian²,Goldstein David³,Chantrill Lorraine A.⁴,Croagh Daniel¹^ORCID,Lawrence Ben⁵,Arnold Dirk⁶,Chau Ian⁷,Obermannova Radka⁸,Price Timothy Jay⁹

Affiliation:

1. Department of Oncology, Monash Medical Centre and Monash University, Melbourne, Australia

2. Department of Oncology, University Cancer Center Leipzig, University Medicine Leipzig, Leipzig, Germany

3. Department of Oncology, Nelune Cancer Centre, Prince of Wales Hospital and University of New South Wales, Sydney, Australia

4. Department of Oncology, The Kinghorn Cancer Centre and University of Western Sydney, Sydney, Australia

5. Department of Oncology, University of Auckland, Auckland, New Zealand

6. Department of Oncology, Instituto CUF de Oncologia, Lisbon, Portugal

7. Department of Oncology, Royal Marsden Hospital, London & Surrey, UK

8. Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic

9. Queen Elizabeth Hospital and Lyell McEwin Hospital, Adelaide, Australia

Funder

Shire Pty Ltd

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2017.1369882

Reference97 articles.

1. Howlader N, Noone A, Krapcho M, et al. SEER cancer statistics review, 1975–2009 (vintage 2009 populations). Bethesda (MD): National Cancer Institute; 2012. p. 1975–2009.

2. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

3. Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

4. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic models to predict survival in patients with pancreatic cancer: a systematic review;HPB;2022-08

2. Prediction of overall survival for metastatic pancreatic cancer: Development and validation of a prognostic nomogram with data from open clinical trial and real‐world study;Cancer Medicine;2018-06